Trekkers' awareness of acute mountain sickness and acetazolamide

Wilderness and Environmental Medicine

Volumn 19, Issue 4, 2008, Pages 321-322

  Subedi, Deepak ^a   Marahatta, Ramesh ^a   Sharma, Shailendra ^a   Bajracharya, Rajan ^a   Hillenbrand, Peter ^a   Soon, Yuen ^b  

^a Birmingham Medical Research Expeditionary Society ^*

^b Birmingham Medical Research Society   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE;

ADULT; AGED; ALTITUDE DISEASE; DATA ANALYSIS; FEMALE; FISHER EXACT TEST; HUMAN; LAKE LOUISE QUESTIONNAIRE; LETTER; MALE; QUESTIONNAIRE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

EID: 57749188037     PISSN: 10806032     EISSN: None     Source Type: Journal    
DOI: 10.1580/07-WEME-LE-179.1     Document Type: Letter

References (5)

1. Lonely Planet Health. Heat, cold, high altitude and motion sickness. Available at: http://www.lonelyplanet.com/health/heat.htm#alt. Accessed November 6, 2006.
2. Roach RC, Bärtsch P, Oelz O, Hackett PH, Lake Louise AMS Scoring Consensus Committee. The Lake Louise acute mountain sickness scoring system. In: Sutton JR, Houston CS, Coates G, eds. Hypoxia and Molecular Medicine. Burlington, VT: Charles S Houston, 1993:272-274.
3. Gertsch JH, Basnyat B, Johnson EW, Onopa J, Holck PS. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). BMJ. 2004;328:797-801.
4. Basnyat B, Gertsch JH, Johnson EW, Castro-Marin F, Inoue Y, Yeh C. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial. High Alt Med Biol. 2003;4:45-52.
5. Birmingham Medical Research Expeditionary Society. Mountain Sickness Study Group. Acetazolamide in control of acute mountain sickness. Lancet. 1981;ii:180-183.